HIV-1 Vpu Mediates HLA-C Downregulation

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Pathogens evade cytotoxic T lymphocytes (CTLs) by downregulating Human Leukocyte Antigen (HLA) molecules.
• Human Immunodeficiency Virus (HIV) typically downregulates HLA-A and -B via Nef, sparing HLA-C to maintain Natural Killer (NK) cell inhibition.
• The precise mechanisms of HIV immune evasion targeting HLA molecules require further elucidation.

Purpose of the Study:

• To investigate the role of HIV Vpu in downregulating HLA-C expression in primary HIV-1 infections.
• To compare HLA-C downregulation by primary HIV-1 clones versus laboratory-adapted strains.
• To assess the impact of HLA-C downregulation on CTL-mediated viral suppression.

Main Methods:

• Analysis of HLA molecule expression in CD4+ T cells infected with various HIV-1 primary clones and laboratory strains.
• Investigation of the role of viral Vpu and Nef proteins in modulating HLA expression using molecular biology techniques.
• Assessment of CTL-mediated suppression of viral replication in vitro using HLA-C-restricted T cell lines.

Main Results:

• Most primary HIV-1 clones, including transmitted founder viruses, downregulate HLA-C, unlike laboratory strains.
• Viral Vpu, not Nef, mediates the downregulation of HLA-C.
• Vpu-mediated HLA-C reduction impairs the ability of HLA-C-restricted CTLs to suppress HIV replication in CD4+ cells.
• Primary HIV-1 clones exhibit variable HLA-C downregulation, potentially reflecting differential immune pressures from CTLs and NK cells.
• HIV-2 also suppresses HLA-C expression via distinct mechanisms.

Conclusions:

• HIV-1 Vpu actively downregulates HLA-C, representing a significant viral immune evasion strategy.
• This downregulation impairs CTL surveillance, shifting the balance of immune response against HIV.
• The differential regulation of HLA molecules by HIV underscores the complex interplay between viral evasion and host immunity, particularly involving CTLs and NK cells.